Peter Sayre, M.D., Ph.D.

Peter H. Sayre, MD, PhD joined in December 2003. He was previously Director, Clinical Development at Titan Pharmaceuticals, Inc., where he directed clinical trials for a novel anti-cancer and bone stabilization agent, and was Director, Clinical Research at Valentis, Inc., where he directed gene therapy clinical trials. He is board-certified in Hematology and in Oncology and is Assistant Clinical Professor of Medicine in the Division of Hematology-Oncology at UCSF.